An increased proportion of inflammatory cells express tumor necrosis factor alpha in idiopathic achalasia of the esophagus

Diseases of the Esophagus

Volumn 22, Issue 5, 2009, Pages 382-385

  Kilic, A ^a   Owens, S R ^a   Pennathur, A ^a   Luketich, J D ^a   Landreneau, R J ^a   Schuchert, M J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Shadyside Medical Building ^*  (United States)

Author keywords

Achalasia; Cytokine; Esophagus; Interleukin; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER SURGERY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS MUSCLE; ESOPHAGUS MYOTOMY; ESOPHAGUS RESECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; COHORT STUDIES; DEGLUTITION DISORDERS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGECTOMY; FEMALE; HUMANS; INTERLEUKIN-2; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MYENTERIC PLEXUS; PRESSURE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67949122069     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00922.x     Document Type: Article

References (20)

1. Raymond L, Lach B, Shamji F M. Inflammatory aetiology of primary oesophageal achalasia: An immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 1999; 35: 455-3.
2. Clark S B, Rice T W, Tubbs R R, Richter J E, Goldblum J R. The nature of the myenteric infiltrate in achalasia: An immunohistochemical analysis. Am J Surg Pathol 2000; 24: 1153-8.
3. Kilic A, Krasinskas A M, Owens S R, Luketich J D, Landreneau R J, Schuchert M J. Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J Surg Res 2007; 143: 177-82.
4. Carter L L, Dutton R W. Type 1 and Type 2: A functional dichotomy for all T-cell subsets. Curr Opin Immunol 1996; 8: 336-42.
5. Annese V, Basciani M, Perri F et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996; 111: 1418-24.
6. Karamanolis G, Sgouros S, Karatzias G et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005; 100: 270-4.
7. Schuchert M J, Luketich J D, Landreneau R J et al. Minimally-invasive esophagomyotomy in 200 consecutive patients: Factors influencing postoperative outcomes. Ann Thorac Surg 2008; 85: 1729-34.
8. Kelsen D P, Ginsberg R, Pajak T F etal. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-84.
9. Birkmeyer J D, Siewers A E, Finlayson E V A et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-37.
10. Hulscher J B, Van Sandick J W, de Boer A G etal. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
11. Swisher S G, Deford L, Merriman K W etal. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119: 1126-32.
12. Zaninotto G, Parenti A R, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000; 87: 1102-5.
13. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999; 230: 392-403.
14. Mearin F, Mourelle M, Guarner F et al. Patients with achalasia lack nitric oxide synthase in the gastro-esophageal junction. Eur J Clin Invest 1993; 23: 724-8.
15. Preiksaitis H G, Tremblay L, Diamant N E. Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig Dis Sci 1994; 39: 770-5.
16. Hurst S M, Stanisz A M, Sharkey K A, Collins S M. Interleukin 1 beta-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993; 105: 1754-60.
17. Bruley des Varannes S, Chevalier J, Pimont S etal. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 2006; 55: 319-26.
18. Venters H D, Tang Q, Liu Q, VanHoy R W, Dantzer R, Kelley K W. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999; 96: 9879-84.
19. Blanco P, Palucka A K, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008; 19: 41-52.
20. Castell D O. Esophageal disorders in the elderly. Gastroenterol Clin North Am 1990; 19: 235-54.